Northwest Biotherapeutics Files Q1 2025 10-Q
Ticker: NWBO · Form: 10-Q · Filed: May 15, 2025 · CIK: 1072379
| Field | Detail |
|---|---|
| Company | Northwest Biotherapeutics Inc (NWBO) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
NWBO Q1 2025 10-Q filed. Financials and ops update.
AI Summary
Northwest Biotherapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Specific financial figures and operational details are available within the full filing.
Why It Matters
This filing provides investors with a quarterly update on Northwest Biotherapeutics' financial health and operational progress, crucial for understanding the company's trajectory in the biopharmaceutical sector.
Risk Assessment
Risk Level: medium — Biopharmaceutical companies often carry higher risk due to the nature of drug development, regulatory hurdles, and market competition.
Key Numbers
- $550,000 — Derivative Gain/Loss (Related Party Transaction)
- $736,000 — Derivative Gain/Loss (Related Party Transaction)
Key Players & Entities
- NORTHWEST BIOTHERAPEUTICS INC (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250515 (date) — Filing Date
- BETHESDA, MD (location) — Business Address
- 001-35737 (other) — SEC File Number
FAQ
What was the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing was March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is the company's primary business address?
The company's business address is 4800 Montgomery Lane, Suite 800, Bethesda, MD 20814.
What is the company's SEC file number?
The company's SEC file number is 001-35737.
What are some of the inputs used for fair value measurements of warrant liability?
Inputs mentioned for fair value measurements of warrant liability include risk-free interest rate, price volatility, expected term, and expected dividend rate.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding NORTHWEST BIOTHERAPEUTICS INC (NWBO).